Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials.
The Journal of dermatological treatment
View this publicationThe Journal of dermatological treatment
View this publicationPsychopharmacology
View this publicationJournal of immunology (Baltimore, Md. : 1950)
View this publicationInfection
View this publicationeLife
View this publicationbioRxiv : the preprint server for biology
View this publicationClinical research in cardiology : official journal of the German Cardiac Society
View this publicationJournal of thrombosis and haemostasis : JTH
View this publicationThe Journal of biological chemistry
View this publicationMolecular therapy. Nucleic acids
View this publication